Lubea completed the acquisition of a 26% stake in Esteve.

Lubea, a private investment firm, completed the acquisition of a 26% stake in Esteve, a pharmaceutical company. Financial terms were not disclosed. "We are thrilled to have Lubea on board as a strategic partner. This investment will provide us with the necessary resources to accelerate our growth and expand our presence in international markets, while remaining true to our purpose of improving people's lives through our innovative pharmaceutical products," Staffan Schüberg, ESTEVE CEO.